• DOI:10.1002/SYN.20246
Corpus ID: 26692212

Development of 5‐HT1A receptor radioligands to determine receptor density and changes in endogenous 5‐HT

@article{Jagoda2006DevelopmentO5,
  title={Development of 5‐HT1A receptor radioligands to determine receptor density and changes in endogenous 5‐HT},
  author={E. Jagoda and L. Lang and Joji Tokugawa and A. Simmons and Y. Ma and C. Contoreggi and D. Kiesewetter and W. Eckelman},
  journal={Synapse},
  year={2006},
  volume={59}
}

E. Jagoda, L. Lang, +5 authors W. Eckelman

Published 2006

Biology, Medicine

Synapse

[18F]FCWAY and [18F]FPWAY, analogues of the high affinity 5‐HT1A receptor (5‐HT1AR) antagonist WAY100635, were evaluated in rodents as potential radiopharmaceuticals for determining 5‐HT1AR density and changes in receptor occupancy due to changes in endogenous serotonin (5‐HT) levels. The in vivo hippocampus specific binding ratio [(hippocampusuptake/cerebellumuptake)−1] of [18F]FPWAY was decreased to 32% of the ratio of [18F]FCWAY, indicating that [18F]FPWAY has lower affinity than [18F]FCWAY… CONTINUE READING

View on Wiley

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed